Page 1926 - Williams Hematology ( PDFDrive )

1900 Part XII: Hemostasis and Thrombosis Chapter 112: Platelet Morphology, Biochemistry, and Function 1901

cell adhesion of fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol 1032. Amann K, et al: Beneficial effects of integrin alphavbeta3-blocking RGD peptides in
107(5):1881–1891, 1988. early but not late phase of experimental glomerulonephritis. Nephrol Dial Transplant
999. Garcia AJ, Huber F, Boettiger D: Force required to break alpha5beta1 integrin- 27(5):1755–1768, 2012.
fibronectin bonds in intact adherent cells is sensitive to integrin activation state. J Biol 1033. Reiser J: Circulating permeability factor suPAR: From concept to discovery to clinic.
Chem 273(18):10988–10993, 1998. Trans Am Clin Climatol Assoc 124:133–138, 2013.
1000. Matsunaga T, et al: Potentiated activation of VLA-4 and VLA-5 accelerates proplate- 1034. Gerber EE, et al: Integrin-modulating therapy prevents fibrosis and autoimmunity in
let-like formation. Ann Hematol 91(10):1633–1643, 2012. mouse models of scleroderma. Nature 503(7474):126–130, 2013.
1001. Plow EF, et al: Related binding mechanisms for fibrinogen, fibronectin, von Wille- 1035. Andrews RK, Lopez JA, Berndt MC: The GPIb-IX-V complex, in Platelets, edited by
brand factor and thrombospondin on thrombin-stimulated human platelets. Blood AD Michelson, pp 145–164. Academic Press, San Diego, 2007.
66:724–727, 1985. 1036. Clemetson KJ, Clemetson JM: Platelet GPIb complex as a target for anti-thrombotic
1002. Schaff M, et al: Integrin alpha6beta1 is the main receptor for vascular laminins and drug development. Thromb Haemost 99(3):473–479, 2008.
plays a role in platelet adhesion, activation, and arterial thrombosis. Circulation 1037. Li R, Emsley J: The organizing principle of the platelet glycoprotein Ib-IX-V complex.
128(5):541–552, 2013. J Thromb Haemost 11(4):605–614, 2013.
1003. Hindriks G, et al: Platelet adhesion to laminin: Role of Ca2+ and Mg2+ ions, shear 1038. Lopez JA, et al: Bernard-Soulier syndrome. Blood 91(12):4397–4418, 1998.
rate, and platelet membrane glycoproteins. Blood 79(4):928–935, 1992. 1039. Lopez JH, et al: The α and β chains of human platelet glycoprotein Ib are both trans-
1004. Sonnenberg A, Modderman PW, Hogervorst F: Laminin receptor on platelets is the membrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci
integrin VLA-6. Nature 336:487–489, 1988. U S A 85:2135–2139, 1988.
1005. Chang JC, et al: The integrin alpha6beta1 modulation of PI3K and Cdc42 activi- 1040. McEwan PA, et al: Quaternary organization of GPIb-IX complex and insights into
ties induces dynamic filopodium formation in human platelets. J Biomed Sci 12(6): Bernard-Soulier syndrome revealed by the structures of GPIbbeta and a GPIbbeta/
881–898, 2005. GPIX chimera. Blood 118(19):5292–5301, 2011.
1006. Tandon NN, et al: Interaction of human platelets with laminin and identification of 1041. Ozaki Y, et al: Platelet GPIb-IX-V-dependent signaling. J Thromb Haemost 3(8):
the 67 kDa laminin receptor on platelets. Biochem J Biochem J 274:535–542, 1991. 1745–1751, 2005.
1007. Arnaout MA, Goodman SL, Xiong JP: Structure and mechanics of integrin-based cell 1042. Roth GJ: Developing relationships: Arterial platelet adhesion, glycoprotein Ib, and
adhesion. Curr Opin Cell Biol 19(5):495–507, 2007. leucine-rich glycoproteins. Blood 77:5–19, 1991.
1008. Hynes RO: Integrins. Bidirectional, allosteric signaling machines. Cell 110(6): 1043. Zhou L, Yang W, Li R: Analysis of inter-subunit contacts reveals the structural mal-
673–687, 2002. leability of extracellular domains in platelet glycoprotein Ib-IX complex. J Thromb
1009. Luo BH, Carman CV, Springer TA: Structural basis of integrin regulation and signal- Haemost 12(1):82–89, 2014.
ing. Annu Rev Immunol 25:619–647, 2002, 2007. 1044. Du X, Beutler L, Ruan C, et al: Glycoprotein Ib and glycoprotein IX are fully com-
1010. Fitzgerald LA, et al: Comparison of cDNA-derived protein sequences of the human plexed in the intact platelet membrane. Blood 69(5):1524–1527, 1987.
fibronectin and vitronectin receptor α subunits and platelet glycoprotein IIb. Biochem- 1045. Hickey MJ, Deaven LL, Roth GJ: Human platelet glycoprotein IX. Characterization of
istry 26:8158–8165, 1987. cDNA and localization of the gene to chromosome 3. FEBS Lett 274:189–192, 1987,
1011. Coller BS, et al: Platelet vitronectin receptor expression differentiates Iraqi-Jewish 1991.
from Arab Patients with Glanzmann thrombasthenia in Israel. Blood 77:75–83, 1991. 1046. Hickey MJ, Williams SA, Roth GJ: Human platelet GPIX: An adhesive prototype of
1012. Byzova TV, Plow EF: Activation of alphaVbeta3 on vascular cells controls recognition leucine-rich glycoproteins with flank-center-flank structures. Proc Natl Acad Sci U S
of prothrombin. J Cell Biol 143(7):2081–2092, 1998. A 86:6773–6777, 1989.
1013. Charo IF, Bekeart LS, Phillips DR: Platelet glycoprotein IIb-IIIa-like proteins mediate 1047. Lopez JA, et al: Efficient plasma membrane expression of a functional platelet gly-
endothelial cell attachment to adhesive proteins and the extracellular matrix. J Biol coprotein Ib-IX complex requires the presence of its three subunits. J Biol Chem
Chem 262:9935–9938, 1987. 267:12851–12859, 1992.
1014. Kieffer N, et al: Adhesive properties of the β3 integrins. Comparison of GPIIb-IIIa and 1048. Bastian LS, et al: Analysis of the megakaryocyte glycoprotein IX promoter identifies
the vitronectin receptor individually expressed in human melanoma cells. J Cell Biol positive and negative regulatory domains and functional GATA and Ets sites. J Biol
113:451–461, 1991. Chem 271(31):18554–18560, 1996.
1015. Lam SC, et al: Isolation and characterization of a platelet membrane protein related to 1049. Block KL, Poncz M: Platelet glycoprotein IIb gene expression as a model of
the vitronectin receptor. J Biol Chem 264:3742–3749, 1989. megakaryocyte-specific expression. Stem Cells, 13(2):135–145, 1995.
1016. Bennett JS, et al: Agonist-activated alphavbeta3 on platelets and lymphocytes binds to 1050. Hashimoto Y, Ware J: Identification of essential GATA and Ets binding motifs
the matrix protein osteopontin. J Biol Chem, 272(13):8137–8140, 1997. within the promoter of the platelet glycoprotein Ib alpha gene. J Biol Chem 270(41):
1017. Reverter JC, et al: Inhibition of platelet-mediated, tissue factor-induced thrombin 24532–24539, 1995.
generation by the mouse/human chimeric 7E3 antibody. Potential implications for 1051. Krause DS, Perkins AS: Gotta find GATA a friend. Nat Med 3(9):960–961, 1997.
the effect of c7E3 Fab treatment on acute thrombosis and “clinical restenosis.” J Clin 1052. Lemarchandel V, et al: GATA and Ets cis-acting sequences mediate megakaryocyte-
Invest 98(3):863–874, 1996. specific expression. Mol Cell Biol 13(1):668–676, 1993.
1018. Beckstead JH, Stenberg PE, McEver RP, et al: Immunohistochemical localization of 1053. Martin F, et al: The transcription factor GATA-1 regulates the promoter activity of the
membrane and alpha-granule proteins in human megakaryocytes: Application to platelet glycoprotein IIb gene. J Biol Chem 268(29):21606–21612, 1993.
plastic-embedded bone marrow biopsy specimens. Blood 67(2):285–293, 1986. 1054. Prandini MH, et al: Characterization of a specific erythromegakaryocytic enhancer
1019. Davies J, et al: The osteoclast functional antigen, implicated in the regulation of bone within the glycoprotein IIb promoter. J Biol Chem 267(15):10370–10374, 1992.
resorption is biochemically related to the vitronectin receptor. J Cell Biol 109:1817, 1989. 1055. Tsang AP, et al: FOG, a multitype zinc finger protein, acts as a cofactor for transcrip-
1020. Feng X, et al: A Glanzmann’s mutation in beta 3 integrin specifically impairs osteoclast tion factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90(1):
function. J Clin Invest 2001;107(9):1137–1144, 1986. 109–119, 1997.
1021. McHugh KP, et al: Mice lacking beta3 integrins are osteosclerotic because of dysfunc- 1056. Uzan G, et al: Tissue-specific expression of the platelet GPIIb gene. J Biol Chem
tional osteoclasts. J Clin Invest 105(4):433–440, 2000. 266(14):8932–8939, 1991.
1022. Savill J, et al: Vitronectin receptor-mediated phagocytosis of cells undergoing apopto- 1057. Lopez JA, Ludwig EW, McCarthy BJ: Polymorphism of human glycoprotein
sis. Nature 343(6254):170–173, 1990. Ibα results from a variable number of repeats of a 13-amino acid sequence in the
1023. Brooks PC, Clark RA, Cheresh DA: Requirement of vascular integrin αVβ3 for angio- mucin-like macroglycopeptide region. Structure function implications. J Biol Chem
genesis. Science 264(5158):569–571, 1994. 267:10055–10061, 1992.
1024. Trikha M, et al: CNTO 95, a fully human monoclonal antibody that inhibits alphav 1058. Carlsson LE, et al: Polymorphisms of the human platelet antigens HPA-1, HPA-
integrins, has antitumor and antiangiogenic activity in vivo. Int J Cancer 110(3): 2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von
326–335, 2004. Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an
1025. Varner JA, Cheresh DA: Integrins and cancer. Curr Opin Cell Biol 8:724–730, 1996. increased risk for stroke. Stroke 28(7):1392–1395, 1997.
1026. Choi ET, et al: Inhibition of neointimal hyperplasia by blocking αVβ3 integrin with a 1059. Shanker J, et al: Platelet function and antiplatelet therapy in cardiovascular disease:
small peptide antagonist GpenGRGDSPCA. J Vasc Surg 19:125–134, 1994. Implications of genetic polymorphisms. Curr Vasc Pharmacol 9(4):479–489, 2011.
1027. Sajid M, Stouffer GA: The role of alpha(v)beta3 integrins in vascular healing. Thromb 1060. Kaski S, Kekomaki R, Partanen J: Systematic screening for genetic polymorphism in
Haemost 87(2):187–193, 2002. human platelet glycoprotein Ibalpha. Immunogenetics 44(3):170–176, 1996.
1028. Stouffer GA, Smyth SS: Effects of thrombin on interactions between beta3-integrins 1061. Suzuki K, et al: StyI polymorphism at nucleotide 1610 in the human platelet glycopro-
and extracellular matrix in platelets and vascular cells. Arterioscler Thromb Vasc Biol tein Ib alpha gene. Jpn J Hum Genet 41(4):419–421, 1996.
23(11):1971–1978, 2003. 1062. Afshar-Kharghan V, et al: Kozak sequence polymorphism of the glycoprotein (GP)
1029. Kaul DK: Sickle red cell adhesion: Many issues and some answers. Transfus Clin Biol Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP
15(1–2):51–55, 2008. Ib- IX-V complex. Blood 94(1):186–191, 1999.
1030. Kaul DK, et al: Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle 1063. Baker RI, et al: Platelet glycoprotein Ibalpha Kozak polymorphism is associated with
red blood cell-endothelium interactions induced by platelet-activating factor. Blood an increased risk of ischemic stroke. Blood 98(1):36–40, 2001.
95(2):368–374, 2000. 1064. Carlsson LE, et al: Platelet receptor and clotting factor polymorphisms as genetic risk
1031. Belcher JD, et al: Heme triggers TLR4 signaling leading to endothelial cell activation factors for thromboembolic complications in heparin-induced thrombocytopenia.
and vaso-occlusion in murine sickle cell disease. Blood 123(3):377–390, 2014. Pharmacogenetics 13(5):253–258, 2003.

Kaushansky_chapter 112_p1829-1914.indd 1901 17/09/15 3:30 pm